Services
Online Inquiry
For research use only. Not intended for any clinical use.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Non-Human Primate (NHP) Advanced Therapy Efficacy Study Services
Are you currently facing long clinical trial timelines, high failure rates, and safety concerns with your cutting-edge therapeutic candidates? Creative Biolabs' NHP Advanced Therapy Efficacy Studies help you de-risk and accelerate your journey from bench to bedside through a comprehensive platform for preclinical evaluation.
The Essential Role of NHP in Cutting-Edge Therapies
NHP models are the gold standard for preclinical evaluation of advanced therapies. Their close genetic, physiological, and immunological similarities to humans provide an unparalleled predictive power, making them indispensable for assessing the efficacy and safety of novel treatments before they enter clinical trials. This is a critical step that provides more accurate predictions of clinical outcomes than smaller animal models.
What Our Service Is
Advanced therapies such as gene and cell therapies, bispecific antibodies, and novel vaccines demand rigorous evaluation in models that closely reflect human biology. Creative Biolabs provides NHP-based efficacy platforms tailored to these cutting-edge modalities, enabling you to generate clinically translatable data that inform both development and regulatory strategies. From early proof-of-concept to pivotal preclinical studies, our models are designed to de-risk programs and accelerate clinical entry.
Services Areas:
- Gene Therapy Models (AAV, Lentivirus): In vivo assessment of biodistribution, transgene expression, durability, and safety in tissue-relevant NHP systems—supporting IND-enabling submissions across neurological, hepatic, and ocular indications.
- Cell Therapy Models (CAR-T, iPSC-derived): Evaluating the homing, persistence, and therapeutic effect of cellular products.
- Antibody & Biologic Efficacy (Bispecifics, ADCs): Determining the therapeutic potential and mechanism of action of complex biologics.
- Vaccine Challenge & Protection Studies: Evaluating vaccine efficacy and immunogenicity against a broad spectrum of infectious disease agents.
Why Choose Us?
The value we create for our customers is centered on mitigating risk and accelerating timelines. We understand the challenges of complex drug development. Our NHP studies are designed to:
- Enhance Translational Success: The data we generate directly addresses the physiological complexities of human disease.
- Identify and Mitigate Risks: We screen for potential safety concerns, such as immunogenicity and off-target effects, early in the development process.
- Optimize Your Candidate: Our studies provide insights that enable you to optimize vector design, delivery routes, and dosing regimens before a clinical trial.
Fig.1 Design of adeno-associated viral vectors for improved utilization in NHPs.1
Key Benefits of Our Service
We pride ourselves on providing a level of service that sets us apart. Our expertise, resources, and commitment to scientific excellence are your project's greatest assets. Our key features include:
- Responsive and Agile: Our team provides rapid turnaround times for study design and initiation, ensuring your project moves forward without delay.
- Extensive NHP Resources: We have access to a large and diverse colony of research-ready NHPs, which includes but not limited to Cynomolgus, Rhesus, Marmoset, and African Green Monkey, allowing us to initiate studies with minimal lead time.
- Unparalleled Customization: Each study is tailored to your specific therapeutic candidate and project goals, providing you with the most relevant and actionable data.
- Comprehensive Reporting: We deliver in-depth reports that go beyond raw data, including thorough analysis, interpretation, and professional conclusions to inform your next steps.
How Creative Biolabs' Service Can Assist Your Project?
Our service is meticulously designed to provide you with actionable solutions and clear deliverables, ensuring your project progresses efficiently and with the highest level of scientific integrity.
01
Required Starting Materials
02
Initial Consultation & Study Design
03
Animal Sourcing & Health Assessment
04
Test Article Administration & In-Life Monitoring
05
Terminal Procedures & Sample Collection
06
Data Analysis & Interpretation
07
Final Reporting
Key Deliverables
- Comprehensive Study Report
- Raw Data Files (PK/PD, Immunogenicity, Biomarker)
- Model Annotations and Histopathology Slides
- High-resolution Imaging Data (MRI, CT, PET)
Capabilities & Partnerships
Service-Specific Data
- Annual Sample Size: Over 50,000 samples analyzed per year.
- Turnaround Time (TAT): Typical turnaround of 2 weeks for bioanalytical results.
- Study Pass Rate: 99%+ success rate in meeting study endpoints.
Our Valued Partners
Frequently Asked Questions
Q: Why are NHP models necessary for my project?
A: Given the unique nature of advanced therapies, which often require precision targeting and can elicit complex immunological responses, small animal models often fall short. NHP models are essential because their physiology and immunology more closely mirror humans, providing a far more accurate and predictive platform for efficacy and safety assessment.
Q: What is the typical timeframe for an NHP study with Creative Biolabs?
A: A typical study timeline ranges from 12 to 24 weeks, but this can vary depending on the complexity of your project. We work closely with you during the initial consultation to create a detailed timeline that aligns with your research and development milestones.
Q: How does Creative Biolabs ensure the ethical treatment of animals in its studies?
A: We uphold exemplary standards of animal welfare, with our facilities and well-trained staff ensuring optimal health and well-being of all animals during the study.
Q: Can you customize a study for my specific therapeutic area or candidate?
A: Absolutely. Our services are fully customizable. We understand that each therapeutic candidate is unique, and our scientific team works with you to design a tailored study protocol that addresses your specific research questions and provides the most relevant data.
Q: How do your services help in de-risking clinical trials?
A: By providing high-quality, predictive data on efficacy, safety, and pharmacology in a human-relevant model, our studies allow you to identify and address potential issues before you invest significant resources in a clinical trial. This early insight increases your chances of success and can save you valuable time and money.
Contact Us
Creative Biolabs' NHP Advanced Therapy Efficacy Studies provide the critical data needed to validate your candidates, de-risk your pipeline, and accelerate your journey toward bringing life-changing treatments to patients. Our dedication to scientific brilliance, paired with our top-tier resources, positions us as the perfect partner for your preclinical research requirements. Contact our team today for more information and to discuss your project.
Reference
- Campos, Lillian J., et al. "Advances in AAV technology for delivering genetically encoded cargo to the nonhuman primate nervous system." Current Research in Neurobiology 4 (2023). Distributed under Open Access license CC BY 4.0, without modification. DOI: https://doi.org/10.1016/j.crneur.2023.100086